Ludwig Cancer Research engages leading scientists and clinicians in an integrated effort to understand and confront the challenge of cancer. The Oxford Branch is based at the University of Oxford, UK and benefits from excellent links with the global Ludwig Cancer Research and local Oxford research communities.
Ludwig Oxford Branch researchers are investigating all stages of cancer, from the risk of disease through to new treatment opportunities. Our research groups are interested in the signalling pathways that influence cancer initiation and progression, with a focus on infection, inflammation and cancer epigenetics. We aim to advance cancer prevention, early diagnosis and effective treatment. Find out more about the Ludwig Oxford research groups.
News
Vacancy: Senior Postdoctoral Scientist - Autoantibodies
26 March 2026
Vacancy: Research Assistant in Brain Tumour Biology
18 March 2026
Publications
Therapeutic manipulation and spatial quantification of the tumor microenvironment in colorectal cancer
Journal article
Mulholland-Illingworth EJ. et al, (2026), Iscience, 29
Toward Integration of Molecular Measures and Artificial Intelligence-Based Assessments With Clinical End Points in Inflammatory Bowel Disease
Journal article
Reinisch W. et al, (2026), Gastroenterology, 170, 686 - 703
Hypoxic regulation of chromatin and gene transcription
Journal article
Kindrick JD. et al, (2026), Communications Biology
Seminars
Targeting T cells to brain tumors
Thursday, 16 April 2026, 11am to 12pm
Speaker(s): Dr Michael Platten
Setting the Speed of DNA Replication: From Helicase Activation to Fork Rate Regulation
Thursday, 23 April 2026, 11am to 12pm
Speaker(s): Dr Joseph Yeeles (MRC Laboratory of Biology)
conference
